AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP 72_CD Form_NN 20-F_JJ Information_NN 2004_CD Group_NNP Profit_NN and_CC Loss_NN Account_NNP for_IN the_DT year_NN ended_VBD 31_CD December_NNP Before_IN exceptional_JJ Exceptional_JJ 2004_CD items_NNS items_NNS Total_JJ Notes_NNP $_$ m_CD $_$ m_CD $_$ m_CD Group_NNP turnover_NN 21,426_CD 21,426_CD Operating_NN costs_NNS 1_CD 16,971_CD 16,971_CD Other_JJ operating_NN income_NN 1_CD 315_CD 315_CD Group_NNP operating_NN profit_NN 1_CD 4,770_CD 4,770_CD Share_NN of_IN operating_VBG profits_NNS of_IN joint_JJ venture_NN 2_CD Profit_NN on_IN sale_NN of_IN interest_NN in_IN joint_JJ venture_NN 3_CD 219_CD 219_CD Dividend_NN income_NN 6_CD 6_CD Profit_NN on_IN ordinary_JJ activities_NNS before_IN interest_NN 4,776_CD 219_CD 4,995_CD Net_JJ interest_NN 490_CD 90_CD Profit_NN on_IN ordinary_JJ activities_NNS before_IN taxation_NN 4,866_CD 219_CD 5,085_CD Taxation_NNP 5_CD 1,321_CD 67_CD 1,254_CD Profit_NN on_IN ordinary_JJ activities_NNS after_IN taxation_NN 3,545_CD 286_CD 3,831_CD Attributable_JJ to_TO minorities_NNS 18_CD 18_CD Net_JJ profit_NN for_IN the_DT financial_JJ year_NN 3,527_CD 286_CD 3,813_CD Dividends_NNS to_TO shareholders_NNS 6_CD 1,555_CD Profit_NN retained_VBN for_IN the_DT financial_JJ year_NN 2,258_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NN before_IN exceptional_JJ items_NNS 7_CD $_$ 2.11_CD $_$ 2.11_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NNP basic_JJ 7_CD $_$ 2.11_CD $_$ 0.17_CD $_$ 2.28_CD Earnings_NNS per_IN $_$ 0.25_CD Ordinary_NNP Share_NNP diluted_VBD 7_CD $_$ 2.11_CD $_$ 0.17_CD $_$ 2.28_CD Weighted_VBN average_JJ number_NN of_IN Ordinary_NNP Shares_NNP in_IN issue_NN millions_NNS 7_CD 1,673_CD All_DT activities_NNS were_VBD in_IN respect_NN of_IN continuing_VBG operations_NNS ._.
There_EX were_VBD no_DT material_NN differences_NNS between_IN reported_VBN profits_NNS and_CC losses_NNS and_CC historical_JJ cost_NN profits_NNS and_CC losses_NNS on_IN ordinary_JJ activities_NNS before_IN taxation_NN ._.
Group_NNP Statement_NNP of_IN Total_NNP Recognised_NNP Gains_NNS and_CC Losses_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2004_CD Notes_NNP $_$ m_CD Net_JJ profit_NN for_IN the_DT financial_JJ year_NN 3,813_CD Foreign_NNP exchange_NN adjustments_NNS on_IN consolidation_NN 20_CD 713_CD Tax_NNP on_IN foreign_JJ exchange_NN adjustments_NNS on_IN consolidation_NN 20_CD 379_CD Translation_NN differences_NNS on_IN foreign_JJ currency_NN borrowings_NNS 20_CD Tax_NNP on_IN translation_NN differences_NNS on_IN foreign_JJ currency_NN borrowings_NNS 20_CD Total_JJ recognized_VBN gains_NNS and_CC losses_NNS relating_VBG to_TO the_DT financial_JJ year_NN 4,905_CD Tax_NNP on_IN foreign_JJ exchange_NN adjustments_NNS on_IN consolidation_NN in_IN 2004_CD includes_VBZ a_DT credit_NN of_IN $_$ 357m_CD in_IN respect_NN of_IN foreign_JJ exchange_NN losses_NNS arising_VBG in_IN 2000_CD see_VBP Note_NN 5_CD ._.
$_$ m_JJ means_NNS millions_NNS of_IN US_NNP dollars_NNS
